Cargando…
The Metabolic Activation of Sofosbuvir Is Impaired in an Experimental Model of NAFLD
SIMPLE SUMMARY: Steatosis is a disease of the liver characterized by the deposition of lipids in hepatocytes. Although the effect of steatosis on the metabolism of drugs has been investigated, the findings obtained so far are still controversial. We here evaluated the pharmacokinetics of the main in...
Autores principales: | Gabbia, Daniela, Roverso, Marco, Sarcognato, Samantha, Zanotto, Ilaria, Ferri, Nicola, Russo, Francesco Paolo, Guido, Maria, Bogialli, Sara, De Martin, Sara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138586/ https://www.ncbi.nlm.nih.gov/pubmed/35625421 http://dx.doi.org/10.3390/biology11050693 |
Ejemplares similares
-
A Nutraceutical Formulation Containing Brown Algae Reduces Hepatic Lipid Accumulation by Modulating Lipid Metabolism and Inflammation in Experimental Models of NAFLD and NASH
por: Gabbia, Daniela, et al.
Publicado: (2022) -
Western Diet-Induced Metabolic Alterations Affect Circulating Markers of Liver Function before the Development of Steatosis
por: Gabbia, Daniela, et al.
Publicado: (2019) -
Self-Emulsifying Formulations to Increase the Oral Bioavailability of 4,6,4′-Trimethylangelicin as a Possible Treatment for Cystic Fibrosis
por: Franceschinis, Erica, et al.
Publicado: (2022) -
Fucus vesiculosus and Ascophyllum nodosum Ameliorate Liver Function by Reducing Diet-Induced Steatosis in Rats
por: Gabbia, Daniela, et al.
Publicado: (2020) -
Depression and Cognitive Impairment—Extrahepatic Manifestations of NAFLD and NASH
por: Colognesi, Martina, et al.
Publicado: (2020)